FindTrial
Sign In

XL999

DRUG10 trials

Sponsors

Symphony Evolution, Inc., John Sarantopoulos

Conditions

AMLAcute Myeloid LeukemiaAdvanced MalignanciesAdvanced MalignancyCancerColorectal CancerMultiple MyelomaNon-Small-Cell Lung Cancer

Phase 1

Study of XL999 in Adults With Solid Tumors
CompletedNCT00104117
Symphony Evolution, Inc.Cancer
Start: 2004-11-30End: 2008-10-31Updated: 2010-02-19
Safety Study of XL999 in Adults With Non-Small-Cell Lung Cancer
TerminatedNCT00491699
Symphony Evolution, Inc.Non-Small-Cell Lung Cancer
Start: 2007-08-31End: 2008-05-31Updated: 2010-02-19
Maintenance Study on the Long Term Safety of XL999
CompletedNCT00955084
Symphony Evolution, Inc.Advanced Malignancies
Start: 2008-08-31End: 2010-05-31Updated: 2010-09-24

Phase 2

Study of XL999 in Patients With Non-small Cell Lung Cancer
TerminatedNCT00277329
Symphony Evolution, Inc.Non-small Cell Lung Cancer
Start: 2005-12-31End: 2008-07-31Updated: 2010-02-22
Study of XL999 in Patients With Metastatic Renal Cell Carcinoma
TerminatedNCT00277316
Symphony Evolution, Inc.Renal Cell Carcinoma
Start: 2005-12-31End: 2007-06-30Updated: 2010-02-19
Study of XL999 in Patients With Metastatic Colorectal Cancer
TerminatedNCT00277303
Symphony Evolution, Inc.Colorectal Cancer
Start: 2005-12-31End: 2007-02-28Updated: 2010-02-22
Study of XL999 in Patients With Previously Treated Ovarian Cancer
TerminatedNCT00277290
Symphony Evolution, Inc.Ovarian Cancer
Start: 2006-01-31End: 2006-11-30Updated: 2010-02-22
Study of XL999 in Patients With Multiple Myeloma
TerminatedNCT00304590
Symphony Evolution, Inc.Multiple Myeloma
Start: 2006-02-28End: 2007-05-31Updated: 2010-02-22
Study of XL999 in Patients With Acute Myeloid Leukemia (AML)
TerminatedNCT00322673
Symphony Evolution, Inc.Acute Myeloid Leukemia, AML
Start: 2006-05-31End: 2007-05-31Updated: 2010-02-22

Unknown Phase

XL999 Administered Intravenously to a Subject With Advanced Malignancies
NCT01945164
John SarantopoulosAdvanced Malignancy
Start: 2010-04-30End: 2012-06-30Updated: 2014-10-21